-+ 0.00%
-+ 0.00%
-+ 0.00%

FAETH THERAPEUTICS ANNOUNCES CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH ROCHE TO EVALUATE PIKTOR IN COMBINATION WITH A SELECTIVE ESTROGEN RECEPTOR DEGRADER IN HR+/HER2- ADVANCED BREAST CANCER

Reuters·11/16/2026 12:00:00

Please log in to view news